St. Luke's John Spertus demonstrates the RESOLVE stroke tool
127 views · Published 18 March 2016 · 3:01 · Indexed 10 November 2026
Channel: Kansas City Star · 2016 · News & Politics
Tissue plasminogen activator, or tPA, can minimize disability in a patient following a stroke, but the drug can also cause catastrophic bleeding in the brain. A national team of researchers, led by cardiologist John Spertus at St. Luke’s Hospital, is hoping to give physicians more confidence with tPA. Spertus, clinical director of Cardiovascular Outcomes Research, demonstrates the RESOLVE tool that can instantly calculate the risks and benefits of tPA for individual stroke patients based on a few simple factors. By Jill Toyoshib
More from this channel
-
1:33
Where's Baby? Heatstroke Awareness Campaign
-
1:42
Sporting KC's Peter Vermes and Chance Myers react to 2-0 win against Colorado
-
1:31
Art Of The Car Concours
-
2:07
51st & Oak Project Kick-Off
-
1:10
Jeopardy! Holds Auditions At Westin Crown Center
-
1:51
KC Senior Speed Dating Redefines The Age Of Love
-
2:47
Royals Ned Yost pregame: Minnesota Twins "playing very well"
-
0:54
Royals Lorenzo Cain on stopping losing streak